Management of pneumothorax in cystic fibrosis*

https://doi.org/10.1016/S0022-3468(83)80207-3Get rights and content

The increased longevity of patients with cystic fibrosis has resulted in a concomitant increase in the frequency with which pneumothorax is seen. While several approaches to this problem have been available from both a medical and surgical standpoint, unsettled questions remain regarding the efficacy of various modalities of therapy. A review of our own experience with 170 episodes of pneumothorax has provided a basis for proposing what appears to be a reasoned approach to therapy. During the past 12 years, 65 patients ages 5 to 32 years experienced 170 episodes of pneumothorax. Of the 211 trials of treatment, all yielded a high rate of initial resolution (70% to 100%) but rates of recurrence were high. The recurrence rates were: observation 60%, thoracentesis 79%, trochar thoractomy 63%, tetracycline sclerosis 86%, and silver nitrate 43%. quinacrine sclerosis yielded an acceptable recurrence rate of 12.5% and partial pleurectomy had no recurrence. There was no statistical difference in the pulmonary function parameters determined before pneumothorax and after chemical pleurodesis or partial pleurectomy. Based upon the data obtained in this review, we recommend that initial management of the pneumothorax include evacuation of the pneumothorax using a chest tube and then chemical pleurodesis using quinacrine sclerosis. In those cases where this pleurodesis fails, upper-partial pleurectomy with obliteration of pleural blebs via a limited thoracentesis is the treatment of choice. An occasional patient requires a concomitant lobectomy.

References (13)

There are more references available in the full text version of this article.

Cited by (22)

  • Prospective randomized trial of silver nitrate vs talc slurry in pleurodesis for symptomatic malignant pleural effusions

    2005, Chest
    Citation Excerpt :

    Stowe and coworkers 26 instilled a 1% SN solution in 10 patients and reported only one recurrence. In contrast, Schuster and coworkers 27 injected a 1% SN solution into the pleural space of eight patients and reported that three patients had a recurrence. Although some authors suggested that it was the agent of choice for pleurodesis, its use was abandoned, probably due to severe pain and the occurrence of large pleural effusions.10

  • Pneumothorax in cystic fibrosis

    2003, Chest
    Citation Excerpt :

    The recurrence of pneumothoraces is common, with one report3 of a patient who experienced 11 separate episodes of pneumothorax. The overall average number of pneumothoraces per patient is 1.92.123456781011131416 The cause of spontaneous pneumothorax in CF patients has not been clearly established.

  • Spontaneous pneumothorax in childhood

    2000, Archives de Pediatrie
View all citing articles on Scopus
*

Presented before the 31st Annual Meeting of the Surgical Section of the American Academy of Pediatrics, New York, New York, October 23–24, 1982.

1

From the Departments of Surgery and Medicine, Children's Hospital Medical Center, and Department of Surgery and Pediatrics, Harvard Medical School, Boston, Mass.

View full text